TREA

88918443 - ZILBRYSQ ZILUCOPLAN

Follow

Information

  • Trademark
  • 88918443
  • Serial Number
    88918443
  • Filing Date
    May 15, 2020
    4 years ago
  • Transaction Date
    June 28, 2021
    2 years ago
  • Status Date
    June 28, 2021
    2 years ago
  • Published for Opposition Date
    September 29, 2020
    3 years ago
  • Location Date
    November 24, 2020
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CARROLL, DORITT
  • Attorney Docket Number
    2011.2004TM
    Attorney Name
    Jennifer Bryan
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
ZILBRYSQ ZILUCOPLAN
Case File Statements
  • CC0000: The colors gray, blue, orange, and red are claimed as features of the mark.
  • D10000: "ZILUCOPLAN"
  • DM0000: The mark consists of the word "ZILUCOPLAN" in gray under the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q".
  • GS0051: Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan
  • GS0101: Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
  • TR0010: The wording "ZILBRYSQ ZILUCOPLAN" has no meaning in a foreign language.
Case File Event Statements
  • 6/28/2021 - 2 years ago
    36 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 6/28/2021 - 2 years ago
    35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 11/24/2020 - 3 years ago
    34 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/29/2020 - 3 years ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/29/2020 - 3 years ago
    32 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/9/2020 - 3 years ago
    31 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/8/2020 - 3 years ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/1/2020 - 3 years ago
    29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/1/2020 - 3 years ago
    28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/1/2020 - 3 years ago
    27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/25/2020 - 3 years ago
    26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/25/2020 - 3 years ago
    25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/25/2020 - 3 years ago
    24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/25/2020 - 3 years ago
    23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/25/2020 - 3 years ago
    22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/24/2020 - 3 years ago
    21 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 8/19/2020 - 3 years ago
    20 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 8/19/2020 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/4/2020 - 3 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/4/2020 - 3 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/4/2020 - 3 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/4/2020 - 3 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/4/2020 - 3 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/28/2020 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/22/2020 - 3 years ago
    12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 7/8/2020 - 3 years ago
    11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 7/8/2020 - 3 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/22/2020 - 3 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 6/18/2020 - 3 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/18/2020 - 3 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/18/2020 - 3 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/18/2020 - 3 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/18/2020 - 3 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/18/2020 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/30/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 5/19/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP